Cognex Corp: Form 10-Q for the period ended Sep 28, 2014
Filed with the SEC on Oct 27, 2014 and accepted by EDGAR at Oct 27, 2014, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-09-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-06-30 to 2014-09-28 | $169.4m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2014-01-01 to 2014-09-28 | $369.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-06-30 to 2014-09-28 | $44.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2014-01-01 to 2014-09-28 | $91.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2014-06-30 to 2014-09-28 | $125.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2014-01-01 to 2014-09-28 | $277.9m | us-gaap:GrossProfit |
| Research and development | 3 months2014-06-30 to 2014-09-28 | $18.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2014-01-01 to 2014-09-28 | $44.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2014-06-30 to 2014-09-28 | $47.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2014-01-01 to 2014-09-28 | $120.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-06-30 to 2014-09-28 | $59.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-01-01 to 2014-09-28 | $112.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2014-06-30 to 2014-09-28 | $10.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2014-01-01 to 2014-09-28 | $20.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-06-30 to 2014-09-28 | $50.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-01-01 to 2014-09-28 | $94.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-06-30 to 2014-09-28 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-01-01 to 2014-09-28 | $1.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-06-30 to 2014-09-28 | $0.58 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2014-01-01 to 2014-09-28 | $1.09 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-06-30 to 2014-09-28 | 89,167,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-01-01 to 2014-09-28 | 89,145,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-01-01 to 2014-09-28 | $63.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2014-01-01 to 2014-09-28 | $9.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2014-01-01 to 2014-09-28 | $35.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-09-28 | $38.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-09-28 | $257.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-09-28 | $816.4m | us-gaap:Assets |
| Current liabilities | At period end2014-09-28 | $78.5m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-09-28 | $734.0m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2014-09-28 | 87,045,169 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000851205-14-000017. Last ingested by Listed: Nov 10, 2026, 23:02 ET. Listed shows no prices and gives no investment advice.